Depletion of Thymus-Derived CD4+CD25+ T Cells Abrogates the Suppressive Effects of α-galactosylceramide Treatment on Experimental Allergic Conjunctivitis
Background: We showed previously that α-galactosylceramide (α-GalCer) treatment elevated splenic CD4+ CD25+Foxp3+ T-cell numbers and suppressed the development of experimental allergic conjunctivitis (EC). Here, we investigated whether CD4+CD25+Foxp3+ T cells mediate the suppressive effects of α-Gal...
Main Authors: | Atsuki Fukushima, Tamaki Sumi, Waka Ishida, Ayako Ojima, Minako Kajisako, Hisayuki Ueno, Osamu Taguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015307796 |
Similar Items
-
Characterization of a Glycolipid Synthase Producing α-Galactosylceramide in <i>Bacteroides fragilis</i>
by: Marc Caballé, et al.
Published: (2022-11-01) -
Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d
by: Katharine Clark, et al.
Published: (2019-10-01) -
Efficient synthesis of α-galactosylceramide and its C-6 modified analogs
by: Huiting Li, et al.
Published: (2022-11-01) -
The PGRMC1 Antagonist AG-205 Inhibits Synthesis of Galactosylceramide and Sulfatide
by: Lihua Wang-Eckhardt, et al.
Published: (2021-12-01) -
The term conjunction and conjunctions in uzbek turkic
by: GÖKHAN ÜNLÜ, et al.
Published: (2023-12-01)